Embark Veterinary, Inc. Selects Colossus Creative Co. as Agency of Record

Feb. 01, 2024

Embark Veterinary, a global leader in dog health and genetics, today announced the appointment of independent creative company Colossus Creative Co. as its agency of record. The collaboration is focused on a transformative brand campaign set to launch in March 2024 spotlighting Embark's unique position in the more than $345 million canine genetics and health industry.

The upcoming brand campaign with Colossus Creative Co. is poised to unveil a fresh and exciting narrative, highlighting Embark's dedication to canine well-being, cutting-edge genetic research, and its role as an industry leader. The campaign is set to launch in March 2024 across various media channels, providing a captivating and immersive experience for audiences.

JR Blaszek, CMO at Embark said:

"Colossus’ creativity, strategic approach, and commitment to excellence align perfectly with our brand values. We believe this collaboration will not only elevate our brand but also create a lasting impact in the industry."

 

Founded in 2015, Embark is the sole canine genetics testing company utilizing research-grade genotyping technology. Its dog DNA tests are built on the leading research platform for dog genetics, analyzing 230,000 genetic markers - more than twice of any competitor. This differentiator underscores Embark's commitment to providing the most accurate and comprehensive insights into canine health.

Embark’s team of dog-loving scientists and veterinarians share a mission of utilizing research and data to advance canine health. Today, Embark's discoveries are propelled by insights from over 2 million dogs in its extensive database, contributing to its mission of transforming the way humans care for dogs.